Mangal Tara Danielle, Molaro Margherita, Nkhoma Dominic, Colbourn Tim, Collins Joseph H, Janoušková Eva, Graham Matthew M, Lin Ines Li, Mnjowe Emmanuel, Mwenyenkulu Tisungane E, Mohan Sakshi, She Bingling, Tamuri Asif U, Twea Pakwanja D, Winskill Peter, Phillips Andrew, Mfutso-Bengo Joseph, Hallett Timothy B
MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, Exhibition Rd, South Kensington, LondonSW7 2AZ, England.
Health Economics and Policy Unit, Kamuzu University of Health Sciences, Lilongwe, Malawi.
Bull World Health Organ. 2025 May 1;103(5):304-315. doi: 10.2471/BLT.24.292439. Epub 2025 Mar 7.
To estimate the outcome of programmes on human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), tuberculosis and malaria in Malawi across multiple health domains.
We used an integrated epidemiological and health system model to estimate the impact of HIV/AIDS, tuberculosis and malaria programmes in Malawi from 2010 to 2019. We incorporated interacting disease dynamics, intervention effects and health system use in the model. We examined four scenarios, comparing actual programme delivery with hypothetical scenarios excluding the health programmes individually and collectively.
From 2010 to 2019, an estimated 1.08 million deaths and 74.89 million disability-adjusted life years were prevented by the HIV/AIDS, tuberculosis and malaria programmes. An additional 15 600 deaths from other causes were also prevented. Life expectancy increased by 13.0 years for males and 16.9 years for females. The programmes accounted for 18.5% (95% uncertainty interval, UI: 18.2 to 18.6) of all health system interactions, including 157.0 million screening and diagnostic tests and 23.2 million treatment appointments. Only 41.5 million additional health worker hours (17.1%; 95% UI: 15.9 to 17.4%) of total health worker time) were needed to achieve these gains. The HIV/AIDS, tuberculosis and malaria programmes required an additional 120.7 million outpatient appointments, which were offset by a net decrease in inpatient care (9.4 million bed-days) that would have been necessary in their absence.
HIV/AIDS, tuberculosis and malaria programmes have greatly increased life expectancy and provided direct and spill-over effects on health in Malawi. These investments reduced the burden on inpatient and emergency care, which requires more intensive health worker involvement.
评估马拉维在多个健康领域实施的人类免疫缺陷病毒和获得性免疫缺陷综合征(HIV/AIDS)、结核病及疟疾防治项目的成效。
我们运用综合流行病学与卫生系统模型,估算2010年至2019年马拉维HIV/AIDS、结核病及疟疾防治项目的影响。模型纳入了相互作用的疾病动态、干预效果及卫生系统利用情况。我们考察了四种情景,将实际项目实施情况与分别及共同排除卫生项目的假设情景进行比较。
2010年至2019年,HIV/AIDS、结核病及疟疾防治项目估计预防了108万例死亡和7489万个伤残调整生命年。还预防了另外15600例由其他原因导致的死亡。男性预期寿命增加了13.0岁,女性增加了16.9岁。这些项目占所有卫生系统相互作用的18.5%(95%不确定性区间,UI:18.2至18.6),包括1.57亿次筛查和诊断检测以及2320万次治疗预约。实现这些成果仅需额外投入4150万卫生工作者工时(占卫生工作者总工时的17.1%;95% UI:15.9至17.4%)。HIV/AIDS、结核病及疟疾防治项目需要额外增加1.207亿次门诊预约,这被住院护理净减少(940万个床位日)所抵消,若没有这些项目,住院护理本会是必要的。
HIV/AIDS、结核病及疟疾防治项目大幅提高了马拉维的预期寿命,并对健康产生了直接和溢出效应。这些投资减轻了住院和急诊护理的负担,而住院和急诊护理需要卫生工作者更多的密集参与。